Drug
Benzocaine
Benzocaine: highest development phase Phase 3, developed by Johnson & Johnson. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Johnson & Johnson
Trials
| Drug | Phase | Indication |
|---|---|---|
| Benzocaine 8 mg NCT03432923 | Phase 3 | Sore Throat |
Latest
No recent events.
Follow Benzocaine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.